BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8748396)

  • 1. Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists.
    Stanhope KJ; McLenachan AP; Dourish CT
    Psychopharmacology (Berl); 1995 Dec; 122(3):268-80. PubMed ID: 8748396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting drug effects on short-term memory function using a combined delayed matching and non-matching to position task.
    Pache DM; Sewell RD; Spencer PS
    J Pharmacol Toxicol Methods; 1999 Aug; 41(4):135-41. PubMed ID: 10691017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT1A receptor agonists improve the performance of normal and scopolamine-impaired rats in an operant delayed matching to position task.
    Cole BJ; Jones GH; Turner JD
    Psychopharmacology (Berl); 1994 Oct; 116(2):135-42. PubMed ID: 7862942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat.
    Dupre KB; Eskow KL; Steiniger A; Klioueva A; Negron GE; Lormand L; Park JY; Bishop C
    Psychopharmacology (Berl); 2008 Jul; 199(1):99-108. PubMed ID: 18545986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat.
    Lüttgen M; Elvander E; Madjid N; Ogren SO
    Neuropharmacology; 2005 May; 48(6):830-52. PubMed ID: 15829255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
    Riekkinen P
    Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral 8-OH-DPAT and scopolamine infused into the frontal cortex produce passive avoidance retention impairments in rats.
    Santucci AC; Shaw C
    Neurobiol Learn Mem; 2003 Mar; 79(2):136-41. PubMed ID: 12591222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the potassium channel blockers, apamin and 4-aminopyridine, on scopolamine-induced deficits in the delayed matching to position task in rats: a comparison with the cholinesterase inhibitor E2020.
    Poorheidari G; Stanhope KJ; Pratt JA
    Psychopharmacology (Berl); 1998 Feb; 135(3):242-55. PubMed ID: 9498727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with a 5HT1A receptor agonist and a muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior.
    Riekkinen M; Sirviö J; Toivanen T; Riekkinen P
    Psychopharmacology (Berl); 1995 Nov; 122(2):137-46. PubMed ID: 8848529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A serotonin-1A receptor agonist and an N-methyl-D-aspartate receptor antagonist oppose each others effects in a genetic rat epilepsy model.
    Filakovszky J; Gerber K; Bagdy G
    Neurosci Lett; 1999 Feb; 261(1-2):89-92. PubMed ID: 10081934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects on delayed non-matching-to-position in rats of microinjections of muscarinic receptor antagonist scopolamine or NMDA receptor antagonist MK-801 into the dorsal or ventral extent of the hippocampus.
    Robinson JK; Mao JB
    Brain Res; 1997 Aug; 765(1):51-60. PubMed ID: 9310393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of galanin on 8-OH-DPAT induced decrease in body temperature and brain 5-hydroxytryptamine metabolism in the mouse.
    Patel S; Hutson PH
    Eur J Pharmacol; 1996 Dec; 317(2-3):197-204. PubMed ID: 8997601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The non-competitive NMDA receptor blocker dizocilpine potentiates serotonergic function.
    Dall'Olio R; Gaggi R; Bonfante V; Gandolfi O
    Behav Pharmacol; 1999 Feb; 10(1):63-71. PubMed ID: 10780303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on performance on two operant timing schedules.
    Chiang TJ; Al-Ruwaitea AS; Mobini S; Ho MY; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2000 Sep; 151(4):379-91. PubMed ID: 11026745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine.
    Zhang Z; Rickard JF; Body S; Asgari K; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 Sep; 181(2):381-91. PubMed ID: 15830225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA antagonists potentiate scopolamine-induced amnesic effect.
    Li HB; Matsumoto K; Tohda M; Yamamoto M; Watanabe H
    Behav Brain Res; 1997 Feb; 83(1-2):225-8. PubMed ID: 9062690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic/serotonergic interactions in hypothermia: implications for rat models of depression.
    Overstreet DH; Daws LC; Schiller GD; Orbach J; Janowsky DS
    Pharmacol Biochem Behav; 1998 Apr; 59(4):777-85. PubMed ID: 9586831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low doses of 8-OH-DPAT prevent the impairment of spatial learning caused by intrahippocampal scopolamine through 5-HT(1A) receptors in the dorsal raphe.
    Carli M; Balducci C; Samanin R
    Br J Pharmacol; 2000 Sep; 131(2):375-81. PubMed ID: 10991934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task.
    Ruotsalainen S; MacDonald E; Koivisto E; Stefanski R; Haapalinna A; Riekkinen P; Sirviö J
    J Psychopharmacol; 1998; 12(2):177-85. PubMed ID: 9694031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NMDA antagonist EAA 494 does not impair working memory in an operant DNMTP task in rats.
    Ballard TM; Mcallister KH
    Pharmacol Biochem Behav; 2000 Apr; 65(4):725-30. PubMed ID: 10764929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.